Skip to main content
European Commission logo print header

Networking Activities for Nanotechnology-Facilitated Cancer Theranostics

Descrizione del progetto

Promuovere la ricerca sulla teranostica del cancro presso l’Istituto di bioscienze in Serbia

Il principale obiettivo del progetto NANOFACTS, finanziato dall’UE, è migliorare e ottimizzare le capacità di ricerca e la collaborazione nell’ambito dei nanomateriali per la teranostica del cancro e della diagnostica basata su sensori tra l’Istituto di bioscienze in Serbia (BIOS) e importanti istituzioni di ricerca in Europa. Tale azione promuoverà e rafforzerà i legami preesistenti con le istituzioni partner ed espanderà l’agenda di ricerca del BIOS. Presso istituzioni partner verranno organizzate varie attività di formazione pratica per i ricercatori del BIOS, mentre in Serbia saranno ospitate lezioni e workshop. La Scuola di farmacia e scienze farmaceutiche del Trinity College a Dublino, in Irlanda, fornirà supporto nell’applicazione delle nanotecnologie per il trattamento e l’immaginografia del cancro, comprese la convalida e la biocompatibilità. Numerosi istituti di chimica presso l’Università tecnica di Vienna in Austria metteranno a disposizione le proprie conoscenze specialistiche per lo sviluppo di biosensori di uso sanitario.

Obiettivo

The main goal of NANOFACTS is to efficiently overcome the networking gaps and deficiencies in research capabilities and collaboration regarding research in cancer theranostics nanomaterials and biosensing diagnostics of cancer, between BIOS and the partner institutions, internationally-leading counterparts at EU level, leading to the enhanced scientific and
technological (S&T) capacity of all the participating institutions with a principal focus on BIOS. In order to widen the research agenda at BIOS with cancer-related research and health-related biosensing technologies, NANOFACTS will harness and improve pre-existing links with two leading European research institutions in the field of nanotechnology and development of biosensors:
• Trinity College Dublin (TCD), Ireland, The School of Pharmacy and Pharmaceutical Sciences, an expert in application of nanotechnology for cancer treatment and imaging; and its validation, including biocompatibility of nanoparticles/nanodevices.
• Vienna University of Technology (TUW), Faculty of Technical Chemistry, Institute of Applied Synthetic Chemistry
and Institute of Chemical Technologies and Analytics, an expert in devising health-related biosensors.
The main strategies to be explored during the project activities will include:
a) BIOS researchers gaining knowledge on devising theranostic nanoparticles for real-time in vivo detection of cancer biomarkers, along with simultaneous targeted cancer therapy and imaging and b) enhancing the capacity of biosensing technologies at BIOS with cancer-related biosensing, including construction of an array of user-friendly personalized point of-care microfluidic and electronic diagnostic devices for electronic and optical sensing of cancer biomarkers, which could be introduced to home disease-monitoring.
Complementarity of the consortium is based on the diversity of the expertise, knowledge and access to the stakeholder communities required for the success of the project.

Invito a presentare proposte

H2020-WIDESPREAD-2018-2020

Vedi altri progetti per questo bando

Bando secondario

H2020-WIDESPREAD-2020-5

Meccanismo di finanziamento

CSA - Coordination and support action

Coordinatore

BIOSENSE INSTITUTE - RESEARCH AND DEVELOPMENT INSTITUTE FOR INFORMATION TECHNOLOGIES IN BIOSYSTEMS
Contribution nette de l'UE
€ 411 500,00
Indirizzo
Dr zorana dindica street 1
21000 Novi sad
Serbia

Mostra sulla mappa

Regione
Србија - север Регион Војводине Јужнобачка област
Tipo di attività
Research Organisations
Collegamenti
Altri finanziamenti
€ 0,00

Partecipanti (2)